Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice

Published:2021-09-13 Issue: Volume: Page:
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:Am J Cardiovasc Drugs

Author:

Rossi Maddalena^ORCID,Fabris Enrico,Barbisan Davide,Massa Laura,Sinagra Gianfranco

Funder

Università degli Studi di Trieste

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40256-021-00497-3.pdf

Reference69 articles.

1. Mathers CD, Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med. 2006;3(11): e442. https://doi.org/10.1371/journal.pmed.0030442.

2. Centre for Economics and Business Research. The economic cost of cardiovascular disease from 2014-2020 in six European economies. 2020.

3. Lowering blood cholesterol to prevent heart disease. NIH Consensus Development Conference statement. Arteriosclerosis 5(4):404–12. http://www.ncbi.nlm.nih.gov/pubmed/3839391.

4. Yusuf S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (Lond, Engl). 2004;364(9438):37–52. https://doi.org/10.1016/S0140-6736(04)17018-9.

5. Sinning D, Landmesser U. Low-density lipoprotein-cholesterol lowering strategies for prevention of atherosclerotic cardiovascular disease: focus on siRNA treatment targeting PCSK9 (Inclisiran). Curr Cardiol Rep. 2020;22(12):176. https://doi.org/10.1007/s11886-020-01427-6.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Biomaterials with Liver X Receptor Agonists Based on the Horizon of Material Biology to Regulate Atherosclerotic Plaque Regression in Situ for Devices Surface Engineering;Regenerative Biomaterials;2024-08-06

2. Lipid-Lowering Medications for Managing Dyslipidemia: A Narrative Review;Cureus;2024-07-23

3. Efficacy, Safety, and Pharmacokinetics of Inclisiran in Japanese Patients: Results from ORION-15;Journal of Atherosclerosis and Thrombosis;2024-06-01

4. Nuevos fármacos hipolipemiantes;FMC - Formación Médica Continuada en Atención Primaria;2023-12

5. Effect of statins combined with PCSK9 inhibitors on the prognosis of patients with acute coronary syndromes after interventional therapy;Cellular and Molecular Biology;2023-11-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3